Business

Add as a preferred source on Google

Johnson & Johnson’s Ollin Biosciences Talks Could Lead to Deal Worth Up to $3.4 Billion

Ollin Biosciences is privately held, and an announcement could come Monday, Nov. 16.

Updated 1 min read
Johnson & Johnson’s New Brunswick headquarters rises above a wet downtown street in New Jersey. / EconoTimes.ai
Johnson & Johnson’s New Brunswick headquarters rises above a wet downtown street in New Jersey. / EconoTimes.ai

The Financial Times, citing people familiar with the talks, reported that Johnson & Johnson is discussing a purchase of privately held Ollin Biosciences valued at up to $3.4 billion; an announcement could come Monday, Nov. 16.

No completed transaction has been announced.

Related articles

View all